TippingPoint Biosciences Raises $4.5M Seed to Drug Hidden Epigenetic Targets in Deadly Pediatric Brain Cancer
Emerging biotechnology company aims to unlock targeting of disease-specific epigenetic protein interfaces to develop next-generation therapies for pediatric cancers SAN FRANCISCO–(BUSINESS WIRE)–TippingPoint Biosciences today announced the closing of an oversubscribed $4.5 million seed financing to advance a…